Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 96 Pages
Report ld: 3502900
Request Sample
Customized Report
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Brain Imaging And Neuroimaging was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Brain Imaging And Neuroimaging was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Brain Imaging And Neuroimaging was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Brain Imaging And Neuroimaging include Varian Medical Systems, General Electric, Siemens AG, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Esaote SpA, Sanrad Medical Systems, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Brain Imaging And Neuroimaging, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Brain Imaging And Neuroimaging by region & country, by Type, and by Application.
The Brain Imaging And Neuroimaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Imaging And Neuroimaging.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Brain Imaging And Neuroimaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Brain Imaging And Neuroimaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Brain Imaging And Neuroimaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Brain Imaging And Neuroimaging Product Introduction
1.2 Global Brain Imaging And Neuroimaging Market Size Forecast
1.2.1 Global Brain Imaging And Neuroimaging Sales Value (2020-2031)
1.2.2 Global Brain Imaging And Neuroimaging Sales Volume (2020-2031)
1.2.3 Global Brain Imaging And Neuroimaging Sales Price (2020-2031)
1.3 Brain Imaging And Neuroimaging Market Trends & Drivers
1.3.1 Brain Imaging And Neuroimaging Industry Trends
1.3.2 Brain Imaging And Neuroimaging Market Drivers & Opportunity
1.3.3 Brain Imaging And Neuroimaging Market Challenges
1.3.4 Brain Imaging And Neuroimaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Brain Imaging And Neuroimaging Players Revenue Ranking (2024)
2.2 Global Brain Imaging And Neuroimaging Revenue by Company (2020-2025)
2.3 Global Brain Imaging And Neuroimaging Players Sales Volume Ranking (2024)
2.4 Global Brain Imaging And Neuroimaging Sales Volume by Company Players (2020-2025)
2.5 Global Brain Imaging And Neuroimaging Average Price by Company (2020-2025)
2.6 Key Manufacturers Brain Imaging And Neuroimaging Manufacturing Base and Headquarters
2.7 Key Manufacturers Brain Imaging And Neuroimaging Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Brain Imaging And Neuroimaging
2.9 Brain Imaging And Neuroimaging Market Competitive Analysis
2.9.1 Brain Imaging And Neuroimaging Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Brain Imaging And Neuroimaging Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Imaging And Neuroimaging as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Functional Magnetic Resonance Imaging (fMRI)
3.1.2 Computed Tomography (CT)
3.1.3 Positron Emission Tomography (PET)
3.2 Global Brain Imaging And Neuroimaging Sales Value by Type
3.2.1 Global Brain Imaging And Neuroimaging Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Brain Imaging And Neuroimaging Sales Value, by Type (2020-2031)
3.2.3 Global Brain Imaging And Neuroimaging Sales Value, by Type (%) (2020-2031)
3.3 Global Brain Imaging And Neuroimaging Sales Volume by Type
3.3.1 Global Brain Imaging And Neuroimaging Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Brain Imaging And Neuroimaging Sales Volume, by Type (2020-2031)
3.3.3 Global Brain Imaging And Neuroimaging Sales Volume, by Type (%) (2020-2031)
3.4 Global Brain Imaging And Neuroimaging Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Clinics and Diagnostic Centers
4.2 Global Brain Imaging And Neuroimaging Sales Value by Application
4.2.1 Global Brain Imaging And Neuroimaging Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Brain Imaging And Neuroimaging Sales Value, by Application (2020-2031)
4.2.3 Global Brain Imaging And Neuroimaging Sales Value, by Application (%) (2020-2031)
4.3 Global Brain Imaging And Neuroimaging Sales Volume by Application
4.3.1 Global Brain Imaging And Neuroimaging Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Brain Imaging And Neuroimaging Sales Volume, by Application (2020-2031)
4.3.3 Global Brain Imaging And Neuroimaging Sales Volume, by Application (%) (2020-2031)
4.4 Global Brain Imaging And Neuroimaging Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Brain Imaging And Neuroimaging Sales Value by Region
5.1.1 Global Brain Imaging And Neuroimaging Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Brain Imaging And Neuroimaging Sales Value by Region (2020-2025)
5.1.3 Global Brain Imaging And Neuroimaging Sales Value by Region (2026-2031)
5.1.4 Global Brain Imaging And Neuroimaging Sales Value by Region (%), (2020-2031)
5.2 Global Brain Imaging And Neuroimaging Sales Volume by Region
5.2.1 Global Brain Imaging And Neuroimaging Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Brain Imaging And Neuroimaging Sales Volume by Region (2020-2025)
5.2.3 Global Brain Imaging And Neuroimaging Sales Volume by Region (2026-2031)
5.2.4 Global Brain Imaging And Neuroimaging Sales Volume by Region (%), (2020-2031)
5.3 Global Brain Imaging And Neuroimaging Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Brain Imaging And Neuroimaging Sales Value, 2020-2031
5.4.2 North America Brain Imaging And Neuroimaging Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Brain Imaging And Neuroimaging Sales Value, 2020-2031
5.5.2 Europe Brain Imaging And Neuroimaging Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Brain Imaging And Neuroimaging Sales Value, 2020-2031
5.6.2 Asia Pacific Brain Imaging And Neuroimaging Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Brain Imaging And Neuroimaging Sales Value, 2020-2031
5.7.2 South America Brain Imaging And Neuroimaging Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Brain Imaging And Neuroimaging Sales Value, 2020-2031
5.8.2 Middle East & Africa Brain Imaging And Neuroimaging Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Brain Imaging And Neuroimaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Brain Imaging And Neuroimaging Sales Value
6.2.1 Key Countries/Regions Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.2.2 Key Countries/Regions Brain Imaging And Neuroimaging Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.3.2 United States Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.4.2 Europe Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.5.2 China Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.5.3 China Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.6.2 Japan Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.7.2 South Korea Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.8.2 Southeast Asia Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Brain Imaging And Neuroimaging Sales Value, 2020-2031
6.9.2 India Brain Imaging And Neuroimaging Sales Value by Type (%), 2024 VS 2031
6.9.3 India Brain Imaging And Neuroimaging Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Varian Medical Systems
7.1.1 Varian Medical Systems Company Information
7.1.2 Varian Medical Systems Introduction and Business Overview
7.1.3 Varian Medical Systems Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Varian Medical Systems Brain Imaging And Neuroimaging Product Offerings
7.1.5 Varian Medical Systems Recent Development
7.2 General Electric
7.2.1 General Electric Company Information
7.2.2 General Electric Introduction and Business Overview
7.2.3 General Electric Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 General Electric Brain Imaging And Neuroimaging Product Offerings
7.2.5 General Electric Recent Development
7.3 Siemens AG
7.3.1 Siemens AG Company Information
7.3.2 Siemens AG Introduction and Business Overview
7.3.3 Siemens AG Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Siemens AG Brain Imaging And Neuroimaging Product Offerings
7.3.5 Siemens AG Recent Development
7.4 Philips Healthcare
7.4.1 Philips Healthcare Company Information
7.4.2 Philips Healthcare Introduction and Business Overview
7.4.3 Philips Healthcare Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Philips Healthcare Brain Imaging And Neuroimaging Product Offerings
7.4.5 Philips Healthcare Recent Development
7.5 Toshiba Medical Systems
7.5.1 Toshiba Medical Systems Company Information
7.5.2 Toshiba Medical Systems Introduction and Business Overview
7.5.3 Toshiba Medical Systems Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Toshiba Medical Systems Brain Imaging And Neuroimaging Product Offerings
7.5.5 Toshiba Medical Systems Recent Development
7.6 Hitachi Medical Systems
7.6.1 Hitachi Medical Systems Company Information
7.6.2 Hitachi Medical Systems Introduction and Business Overview
7.6.3 Hitachi Medical Systems Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hitachi Medical Systems Brain Imaging And Neuroimaging Product Offerings
7.6.5 Hitachi Medical Systems Recent Development
7.7 Esaote SpA
7.7.1 Esaote SpA Company Information
7.7.2 Esaote SpA Introduction and Business Overview
7.7.3 Esaote SpA Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Esaote SpA Brain Imaging And Neuroimaging Product Offerings
7.7.5 Esaote SpA Recent Development
7.8 Sanrad Medical Systems
7.8.1 Sanrad Medical Systems Company Information
7.8.2 Sanrad Medical Systems Introduction and Business Overview
7.8.3 Sanrad Medical Systems Brain Imaging And Neuroimaging Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sanrad Medical Systems Brain Imaging And Neuroimaging Product Offerings
7.8.5 Sanrad Medical Systems Recent Development
8 Industry Chain Analysis
8.1 Brain Imaging And Neuroimaging Industrial Chain
8.2 Brain Imaging And Neuroimaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Brain Imaging And Neuroimaging Sales Model
8.5.2 Sales Channel
8.5.3 Brain Imaging And Neuroimaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
The global Brain Imaging And Neuroimaging market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Brain Imaging And Neuroimaging market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
The global market for Brain Imaging And Neuroimaging was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 87
USD 2900.00
(Single User License)
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 83
USD 2900.00
(Single User License)
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 130
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 117
The global Brain Imaging And Neuroimaging market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Brain Imaging And Neuroimaging market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
The global market for Brain Imaging And Neuroimaging was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 87
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 83
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now